AgenciesUS pharma major is in the final stages to get approval for the COVID-19 vaccine in India. The news comes amid reports that the government is in talks with the US pharma major to find a middle-ground for supplying vaccines in India.
Pfizer now in final stages to get approval for #COVID19 vaccine in India. I hope very soon we will finalize an agreement with the govt, said Pfizer CEO Albert Bourla to news agency ANI.
Allowing the Pfizer vaccine will make it the second foreign vaccine to be cleared for use in India, after Sputnik V. The approval is expected to further boost the immunisation exercise in the country.
In April, India invited Moderna, Johnson and Johnson and Pfizer to supply their vaccines in the Indian market in the middle of the second wave of COVID-19. India has, however, not signed any deal with the pharma giant as the latter has reportedly not supplied vaccines in any country without signing an indemnity for adverse effects of their vaccines on the population.
Pfizer now in final stages to get approval for #COVID19 vaccine in India. I hope very soon we will finalize an agreement with the govt, said Pfizer CEO Albert Bourla to news agency ANI.
Allowing the Pfizer vaccine will make it the second foreign vaccine to be cleared for use in India, after Sputnik V. The approval is expected to further boost the immunisation exercise in the country.
In April, India invited Moderna, Johnson and Johnson and Pfizer to supply their vaccines in the Indian market in the middle of the second wave of COVID-19. India has, however, not signed any deal with the pharma giant as the latter has reportedly not supplied vaccines in any country without signing an indemnity for adverse effects of their vaccines on the population.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.